Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    October 2019
  1. LEE AK, Woodward M, Wang D, Ohkuma T, et al
    The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
    J Clin Endocrinol Metab. 2019 Oct 7. pii: 5582233. doi: 10.1210.
    PubMed     Text format     Abstract available


    August 2019
  2. GYAWALI P, Martin SA, Heilbronn LK, Vincent AD, et al
    Higher serum sex hormone-binding globulin (SHBG) levels are associated with incident cardiovascular disease (CVD) in men.
    J Clin Endocrinol Metab. 2019 Aug 7. pii: 5544495. doi: 10.1210/jc.2019-01317.
    PubMed     Text format     Abstract available


  3. DI DALMAZI G, Fanelli F, Zavatta G, Ricci Bitti S, et al
    The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk.
    J Clin Endocrinol Metab. 2019 Aug 5. pii: 5542836. doi: 10.1210/jc.2019-00365.
    PubMed     Text format     Abstract available


    July 2019
  4. MELHUS H, Michaelsson K, Larsson SC
    Serum Parathyroid Hormone and Risk of Coronary Artery Disease: Exploring Causality using Mendelian Randomization.
    J Clin Endocrinol Metab. 2019 Jul 16. pii: 5532038. doi: 10.1210/jc.2019-01063.
    PubMed     Text format     Abstract available


    June 2019
  5. ALEKSANDROVA K, Drogan D, Weikert C, Schulze MB, et al
    Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction and Stroke: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2019 Jun 18. pii: 5519297. doi: 10.1210/jc.2019-00477.
    PubMed     Text format     Abstract available


  6. POTT J, Bae YJ, Horn K, Teren A, et al
    Genetic association study of eight steroid hormones and implications for sexual dimorphism of coronary artery disease.
    J Clin Endocrinol Metab. 2019 Jun 6. pii: 5511541. doi: 10.1210/jc.2019-00757.
    PubMed     Text format     Abstract available


    May 2019
  7. VACCARO O, Lucisano G, Masulli M, Bonora E, et al
    Cardiovascular effects of pioglitazone or sulphonylureas according to pretreatment risk: moving towards personalized care.
    J Clin Endocrinol Metab. 2019 May 6. pii: 5485080. doi: 10.1210/jc.2019-00361.
    PubMed     Text format     Abstract available


    April 2019
  8. HARADA M, Fujihara K, Osawa T, Yamamoto M, et al
    Relationship between Number of Multiple Risk Factors and Coronary Artery Disease Risk With and Without Diabetes Mellitus.
    J Clin Endocrinol Metab. 2019 Apr 17. pii: 5469228. doi: 10.1210/jc.2019-00168.
    PubMed     Text format     Abstract available


  9. HIEMSTRA T, Lim K, Thadhani R, Manson JE, et al
    Vitamin D and Atherosclerotic Cardiovascular Disease.
    J Clin Endocrinol Metab. 2019 Apr 4. pii: 5426811. doi: 10.1210/jc.2019-00194.
    PubMed     Text format     Abstract available


  10. BANO A, Chaker L, de Maat MPM, Atiq F, et al
    Thyroid function and cardiovascular disease: the mediating role of coagulation factors.
    J Clin Endocrinol Metab. 2019 Apr 2. pii: 5423567. doi: 10.1210/jc.2019-00072.
    PubMed     Text format     Abstract available


    March 2019
  11. MORENO RC, Navas-Acien A, Escolar E, Nathan DM, et al
    Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 14. pii: 5376633. doi: 10.1210/jc.2018-01484.
    PubMed     Text format     Abstract available


  12. EJLSMARK-SVENSSON H, Rolighed L, Rejnmark L
    Effect of Parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: A randomised clinical trial.
    J Clin Endocrinol Metab. 2019 Mar 12. pii: 5372733. doi: 10.1210/jc.2018-02456.
    PubMed     Text format     Abstract available


    February 2019
  13. NATTERO-CHAVEZ L, Redondo Lopez S, Alonso Diaz S, Garnica Urena M, et al
    Association of cardiovascular autonomic dysfunction with peripheral arterial stiffness in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342945. doi: 10.1210/jc.2018-02729.
    PubMed     Text format     Abstract available


  14. HUANG RC, Lillycrop KA, Beilin LJ, Godfrey KM, et al
    Epigenetic age acceleration in adolescence associates with BMI, inflammation and risk score for middle age cardiovascular disease.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342941. doi: 10.1210/jc.2018-02076.
    PubMed     Text format     Abstract available


  15. SCHADE DS, Eaton RP
    A Simplified Approach to Reducing Cardiovascular Risk.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342943. doi: 10.1210/jc.2018-02509.
    PubMed     Text format     Abstract available


  16. BEHESHTI S, Madsen CM, Varbo A, Nordestgaard BG, et al
    How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia.
    J Clin Endocrinol Metab. 2019 Feb 7. pii: 5307688. doi: 10.1210/jc.2018-02261.
    PubMed     Text format     Abstract available


  17. JUONALA M, Pitkanen N, Tolonen S, Laaksonen M, et al
    Childhood exposure to passive smoking and bone health in adulthood. The Cardiovascular Risk in Young Finns Study.
    J Clin Endocrinol Metab. 2019 Feb 1. pii: 5304739. doi: 10.1210/jc.2018-02501.
    PubMed     Text format     Abstract available


    January 2019
  18. SKOV J, Sundstrom A, Ludvigsson JF, Kampe O, et al
    Sex-specific risk of cardiovascular disease in autoimmune Addison's disease - a population-based cohort study.
    J Clin Endocrinol Metab. 2019 Jan 3. pii: 5270381. doi: 10.1210/jc.2018-02298.
    PubMed     Text format     Abstract available


    November 2018
  19. OH TJ, Moon JH, Choi SH, Lim S, et al
    Body-weight fluctuation and incident diabetes mellitus, cardiovascular disease, and mortality: a 16-year prospective cohort study.
    J Clin Endocrinol Metab. 2018 Nov 29. pii: 5214055. doi: 10.1210/jc.2018-01239.
    PubMed     Text format     Abstract available


  20. GUASCH-FERRE M, Ruiz-Canela M, Li J, Zheng Y, et al
    Plasma acylcarnitines and risk of type 2 diabetes in a Mediterranean population at high cardiovascular risk.
    J Clin Endocrinol Metab. 2018 Nov 13. pii: 5172268. doi: 10.1210/jc.2018-01000.
    PubMed     Text format     Abstract available


    September 2018
  21. TAMHANE S, Rodriguez-Gutierrez R, Iqbal AM, Prokop L, et al
    Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2018 Sep 28. pii: 5107761. doi: 10.1210/jc.2018-01862.
    PubMed     Text format     Abstract available


  22. AL-SOFIANI ME, Yanek LR, Faraday N, Kral BG, et al
    Diabetes and Platelet Response to Low-dose Aspirin.
    J Clin Endocrinol Metab. 2018 Sep 27. pii: 5107300. doi: 10.1210/jc.2018-01254.
    PubMed     Text format     Abstract available


  23. RITCHEY ME, Harding A, Hunter S, Peterson C, et al
    Cardiovascular Safety During and After Use of Phentermine and Topiramate.
    J Clin Endocrinol Metab. 2018 Sep 21. pii: 5104461. doi: 10.1210/jc.2018-01010.
    PubMed     Text format     Abstract available


    August 2018
  24. STRAND E, Rebnord EW, Pedersen ER
    Response to letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073239. doi: 10.1210/jc.2018-01647.
    PubMed     Text format    


  25. LIEPINSH E, Dambrova M
    Letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073236. doi: 10.1210/jc.2018-01408.
    PubMed     Text format    


  26. EMANUELSSON F, Nordestgaard BG, Benn M
    Familial hypercholesterolemia and risk of peripheral arterial disease and chronic kidney disease.
    J Clin Endocrinol Metab. 2018 Aug 3. pii: 5063925. doi: 10.1210/jc.2018-01058.
    PubMed     Text format     Abstract available


  27. HSU PF, Sung SH, Cheng HM, Shin SJ, et al
    Cardiovascular benefits of acarbose versus sulfonylureas in type 2 diabetic patients treated with metformin.
    J Clin Endocrinol Metab. 2018 Aug 2. pii: 5063484. doi: 10.1210/jc.2018-00040.
    PubMed     Text format     Abstract available


    July 2018
  28. LYU Y, Luo Y, Li C, Guo X, et al
    Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China.
    J Clin Endocrinol Metab. 2018 Jul 3. pii: 5047769. doi: 10.1210/jc.2018-00422.
    PubMed     Text format     Abstract available


    May 2018
  29. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005949. doi: 10.1210/jc.2018-00470.
    PubMed     Text format     Abstract available


  30. PARK J, Blackburn BE, Ganz PA, Rowe K, et al
    Risk Factors for Cardiovascular Disease among Thyroid Cancer Survivors: Findings from the Utah Cancer Survivors Study.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005948. doi: 10.1210/jc.2017-02629.
    PubMed     Text format     Abstract available


  31. THURSTON RC, Bhasin S, Chang Y, Barinas Mitchell E, et al
    Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women.
    J Clin Endocrinol Metab. 2018 May 18. pii: 4999000. doi: 10.1210/jc.2018-00579.
    PubMed     Text format     Abstract available


  32. OTTOSSON F, Smith E, Melander O, Fernandez C, et al
    Altered asparagine and glutamate homeostasis precede coronary artery disease and type-2 diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996516. doi: 10.1210/jc.2018-00546.
    PubMed     Text format     Abstract available


    April 2018
  33. STAHLI BE, Nozza A, Schrieks IC, Buse JB, et al
    Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome.
    J Clin Endocrinol Metab. 2018 Apr 6. pii: 4963641. doi: 10.1210/jc.2017-02772.
    PubMed     Text format     Abstract available


    March 2018
  34. FAWAD A, Bergmann A, Struck J, Nilsson PM, et al
    Proneurotensin predicts cardiovascular disease in an elderly population.
    J Clin Endocrinol Metab. 2018 Mar 13. pii: 4931667. doi: 10.1210/jc.2017-02424.
    PubMed     Text format     Abstract available


  35. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Response to Letter: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931069. doi: 10.1210/jc.2018-00244.
    PubMed     Text format    


  36. PASCHOU SA, Anagnostis P, Goulis DG, Siasos G, et al
    Letter to the Editor: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931067. doi: 10.1210/jc.2018-00018.
    PubMed     Text format    


    February 2018
  37. MEUN C, Franco OH, Dhana K, Jaspers L, et al
    High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study.
    J Clin Endocrinol Metab. 2018 Feb 1. pii: 4834041. doi: 10.1210/jc.2017-02421.
    PubMed     Text format     Abstract available


    January 2018
  38. WU CJ, Kao TW, Chang YW, Peng TC, et al
    Does the additional component of calf-circumference refine metabolic syndrome in Correlating with Cardiovascular Risk?
    J Clin Endocrinol Metab. 2018 Jan 15. pii: 4802111. doi: 10.1210/jc.2017-02320.
    PubMed     Text format     Abstract available


  39. DEGERUD E, Nygard O, de Vogel S, Hoff R, et al
    Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794886. doi: 10.1210/jc.2017-02328.
    PubMed     Text format     Abstract available


  40. STRAND E, Rebnord EW, Flygel MR, Lysne V, et al
    Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794884. doi: 10.1210/jc.2017-02139.
    PubMed     Text format     Abstract available


  41. YU D, Cai Y, Graffy J, Holman D, et al
    Development and external validation of risk scores for cardiovascular hospitalisation and rehospitalisation in diabetes patients.
    J Clin Endocrinol Metab. 2018 Jan 8. pii: 4792932. doi: 10.1210/jc.2017-02293.
    PubMed     Text format     Abstract available


    December 2017
  42. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2017 Dec 6. pii: 4693937. doi: 10.1210/jc.2017-01829.
    PubMed     Text format     Abstract available


    October 2017
  43. TROISI R, Titus L, Hatch EE, Palmer JR, et al
    A Prospective Cohort Study of Prenatal Diethylstilbestrol Exposure and Cardiovascular Disease Risk.
    J Clin Endocrinol Metab. 2017 Oct 20. doi: 10.1210/jc.2017-01940.
    PubMed     Text format     Abstract available


  44. ANEKE-NASH CS, Xue X, Qi Q, Biggs ML, et al
    The Association between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study.
    J Clin Endocrinol Metab. 2017 Oct 12. doi: 10.1210/jc.2017-01273.
    PubMed     Text format     Abstract available


    September 2017
  45. RHEE EJ, Cho JH, Kwon H, Park SE, et al
    Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study.
    J Clin Endocrinol Metab. 2017 Sep 27. doi: 10.1210/jc.2017-01723.
    PubMed     Text format     Abstract available


  46. PLAT J, Vreugdenhil ACE
    Response to Letter: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01894.
    PubMed     Text format    


  47. RADETTI G, Longhi S, Sartorio A, Grugni G, et al
    Letter to the Editor: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01505.
    PubMed     Text format    


  48. BERGTHORSDOTTIR R, Ragnarsson O, Skrtic S, Glad CAM, et al
    Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients with Addison's Disease; a case-control study.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01324.
    PubMed     Text format     Abstract available


  49. MARAKA S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, et al
    Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01643.
    PubMed     Text format     Abstract available


  50. KANG YM, Cho YK, Lee SE, Park JY, et al
    Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study.
    J Clin Endocrinol Metab. 2017;102:3443-3451.
    PubMed     Text format     Abstract available


    August 2017
  51. MONGRAW-CHAFFIN ML, Allison MA, Burke GL, Criqui MH, et al
    CT derived body fat distribution and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    J Clin Endocrinol Metab. 2017 Aug 16. doi: 10.1210/jc.2017-01113.
    PubMed     Text format     Abstract available


    February 2017
  52. TOULIS KA, Willis BH, Marshall T, Kumarendran B, et al
    All-cause mortality in patients with diabetes under treatment with dapagliflozin: a population-based, open-cohort study in THIN database.
    J Clin Endocrinol Metab. 2017 Feb 20. doi: 10.1210/jc.2016-3446.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: